T. Rowe Price Associates »

Optinose shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Optinose (OPTN) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Optinose

Tip: Access up to 7 years of quarterly data

All positions including Optinose held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Optinose by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $23k 18k 1.31
2023-09-30 $19k 15k 1.28
2023-06-30 $274k 223k 1.23

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Apple Comm Stk (AAPL)
Amazon Comm Stk (AMZN)
Nvidia Corporation Comm Stk (NVDA)
Meta Platforms Comm Stk (META)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Unitedhealth Group Comm Stk (UNH)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Intuit Comm Stk (INTU)
Servicenow Comm Stk (NOW)
Fiserv Comm Stk (FI)

View all positions for T. Rowe Price Associates

Top funds holding Optinose

MVM Partners
Dr. Jeffrey R. Jay, M.D.
Rosalind Advisors
BlackRock
Vanguard Group
Bleichroeder
Kingdon Capital Management
Nantahala Capital Management
Massachusetts Financial Services
Levin Easterly Partners
Rice Hall James & Associates
Prescott Group Capital Management
Bank of New York Mellon
GMT Capital Corp
Charles Schwab Investment Management

View all funds holding Optinose